Over 10 years we help companies reach their financial and branding goals. Engitech is a values-driven technology agency dedicated.



411 University St, Seattle, USA

+1 -800-456-478-23


Myeloid Therapeutics Appoints Leading Immunologist, Cell & Gene Therapy Expert Bruce McCreedy, Ph.D.

Dr. McCreedy brings decades of executive-level biopharmaceutical experience to advance research and development of novel myeloid-targeting therapies. CAMBRIDGE, Mass., May 4, 2021 /PRNewswire/ — Myeloid Therapeutics, Inc., a clinical-stage immunology company that is combining RNA insights with new technology to develop powerful cancer therapies, today announced that industry veteran Bruce McCreedy, Ph.D., has joined the […]


Myeloid Therapeutics Appoints Elaine Jones, Ph.D., to its Board of Directors

Industry veteran will draw on unique mix of scientific and business acumen to support Company’s efforts to combat cancer with growing portfolio of novel myeloid-targeting therapies CAMBRIDGE, Mass., March. 31, 2021 /PRNewswire/ — Myeloid Therapeutics, Inc., a clinical-stage immunology company focused on combining RNA insights with cutting edge technologies for new cancer therapies, today announced […]


Myeloid Therapeutics Launches with Over $50 Million in Financing and Two Clinical Trials

Myeloid’s cell therapy harnesses the innate capabilities of myeloid lineage cells to fight cancer. Scientific founders include world-renowned cell therapy & cancer experts Ronald Vale, Ph.D. and Siddhartha Mukherjee, M.D., D.Phil. Co-Founded by Thomas Cahill, M.D., Ph.D., with financing led by Newpath Partners and participation from leading biotech investors CAMBRIDGE, Mass., Jan. 6, 2021 /PRNewswire/ […]


Myeloid Therapeutics to Present at the Jefferies 2020 Virtual Healthcare Conference

CAMBRIDGE, Mass., June 2, 2020 – Myeloid Therapeutics, a biotech company harnessing the innate immune system to eradicate cancer and other diseases, today announced a presentation at the Jefferies 2020 Virtual Healthcare Conference. Chief Scientific Officer Daniel Getts, Ph.D., will give a company overview and provide an update on its lead oncology and COVID-19 programs […]